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Abstract: Mycobacterium tuberculosis (Mtb) has evolved
into a highly successful human pathogen. It deftly
subverts the bactericidal mechanisms of alveolar macro-
phages, ultimately inducing granuloma formation and
establishing long-term residence in the host. These
hallmarks of Mtb infection are facilitated by the metabolic
adaptation of the pathogen to its surrounding environ-
ment and the biosynthesis of molecules that mediate its
interactions with host immune cells. The sulfate assimila-
tion pathway of Mtb produces a number of sulfur-
containing metabolites with important contributions to
pathogenesis and survival. This pathway is regulated by
diverse environmental cues and regulatory proteins that
mediate sulfur transactions in the cell. Here, we discuss
the transcriptional and biochemical mechanisms of sulfur
metabolism regulation in Mtb and potential small
molecule regulators of the sulfate assimilation pathway
that are collectively poised to aid this intracellular
pathogen in its expert manipulation of the host. From
this global analysis, we have identified a subset of sulfur-
metabolizing enzymes that are sensitive to multiple
regulatory cues and may be strong candidates for
therapeutic intervention.
Introduction
Mycobacterium tuberculosis (Mtb), the bacterium that causes
tuberculosis in humans, infects roughly 2 billion people worldwide
[1]. However, less than 1% of those infected with Mtb show signs
of active disease [2]. The majority of infected individuals have a
latent infection characterized by dormant, nonreplicating bacteria
that persist within a mass of immune cells in the lung [3]. These
cells form a protective barrier between the bacteria and
surrounding tissue known as the granuloma [4,5]. When host
immunity is compromised, the granuloma deteriorates, liberating
the confined bacteria and reactivating the disease.
In order to mount a latent infection, Mtb must withstand
phagocytosis by alveolar macrophages, the host’s primary line of
defense against airborne pathogens [5]. By evading typical
bactericidal processes, Mtb is able to replicate and eventually
induce granuloma formation [3]. The mechanisms by which Mtb
persists in the hostile phagosomal environment and orchestrates
the transition to latency are ill defined. Elucidating the molecular
machinery and metabolic pathways that facilitate these pivotal
events is crucial to identifying new therapeutic targets for this
global human pathogen.
There is a growing body of evidence that supports a role for
sulfur-containing metabolites in Mtb pathogenesis [6,7]. Sulfated
molecules from Mtb have been intimately linked to bacterial
virulence (Figure 1A) [8–10]. For example, the prominent cell
wall-associated glycolipid Sulfolipid-1 is only produced by
pathogenic species of mycobacteria [8,11], and its biosynthetic
precursor SL1278, named for its observed mass, has been shown to
elicit cytokine production in human tuberculosis patients [10]. On
the contrary, biosynthesis of the sulfated menaquinone S881
suppresses bacterial virulence [9]. Reduced sulfur compounds
(Figure 1B), such as cysteine and methionine, also contribute to
Mtb pathogenesis [6]. Disabling their biosynthesis dramatically
attenuates bacterial virulence and persistence during the chronic
phase of infection in mice [12]. Mycothiol (MSH), the primary
thiol-containing small molecule of mycobacteria [13], is instru-
mental in the detoxification of numerous bactericidal agents and
confers protection against oxidative stress [14–16]. Biosynthesis of
these important sulfur-containing metabolites relies on the sulfate
assimilation pathway [17].
The sulfate assimilation pathway (Figure 2) is composed of a
group of enzymes that catalyze the uptake and metabolism of
inorganic sulfate from the host [7]. This pathway commences with
the active import of sulfate, which is subsequently adenylated by
ATP sulfurylase, an enzyme containing both GTPase and
sulfurylase domains [18]. The resulting product, adenosine 59-
phosposulfate (APS), can be reduced to sulfite by APS reductase
for the biosynthesis of reduced sulfur species via the reductive
branch of the pathway [19]. Alternatively, because APS constitutes
a metabolic branchpoint, it can be phosphorylated at the 39-
position by APS kinase to generate 39-phosphoadenosine 59-
phosphosulfate (PAPS), the universal sulfate donor in the cell [17].
PAPS is a substrate for sulfotransferases, enzymes that catalyze the
transfer of its sulfate group onto bacterial metabolites [11].
Collectively, these reactions constitute the sulfation branch of the
sulfate assimilation pathway.
The regulation of Mtb sulfur metabolism relies on the
transcriptional response of sulfate assimilation enzymes to diverse
environmental cues and regulatory proteins that influence flux
through the sulfate assimilation pathway. Further, small molecule
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PLoS Pathogens | www.plospathogens.org 1 July 2011 | Volume 7 | Issue 7 | e1002036Figure 1. Sulfur-containing metabolites from Mtb. (A) Sulfated compounds, clockwise from top: S881, Sulfolipid-1, SL1278. (B) Reduced sulfur
compounds, from top to bottom: MSH, cysteine, methionine.
doi:10.1371/journal.ppat.1002036.g001
Figure 2. The sulfate assimilation pathway of Mtb. Inorganic sulfate from the host is converted to APS by ATP sulfurylase. APS is either
sequentially reduced by APS reductase and sulfite reductase for the biosynthesis of essential reduced sulfur metabolites (reductive branch), or
phosphorylated by APS kinase to generate PAPS, a substrate for sulfotransferases (sulfation branch). PAP, a byproduct of sulfotransferase reactions, is
degraded by the PAP(S) phosphatase CysQ, which also converts PAPS to APS.
doi:10.1371/journal.ppat.1002036.g002
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mechanisms may modulate related transcriptional circuits in Mtb.
Here, we review each of these regulatory elements in an effort to
guide our understanding of how the sulfate assimilation pathway
facilitates bacterial adaptation to the host.
Transcriptional Regulation of Sulfur Metabolism
Genes
Transcriptional profiling has demonstrated that Mtb sulfur
metabolism genes are dynamically regulated by diverse environ-
mental cues (Table 1) [20–29]. This finding is perhaps not
surprising, given the demonstrated importance of the sulfate
assimilation pathway to bacterial survival [6] and the hostile
conditions encountered by bacteria in the phagosome [30]. For
example, upon phagocytosis, bacteria are exposed to oxidative
stress and deprived of essential nutrients [30,31]. Microarray
analysis has shown that these conditions elicit the upregulation of
key genes from the sulfate assimilation pathway (Table 1)
[21,22,26,27]. Genes encoding the primary sulfate transport
complex of Mtb are induced following treatment with hydrogen
peroxide (cysT) and nutrient starvation (cysA1, cysT, cysW, subI),
conditions that also induce the ATP sulfurylase genes cysD and
cysN, as well as the cysC gene that encodes APS kinase (in Mtb, cysC
is fused to cysN, yielding a bifunctional cysNC gene [18]). Given
that these genes coordinate the first few steps of the sulfate
assimilation pathway, their induction is most likely accompanied
by an increase in the biosynthesis of sulfur-containing metabolites
that protect the pathogen during the course of infection, though
this remains to be demonstrated. Notably, cysD and cysNC are also
induced during macrophage infection, underscoring the impor-
tance of sulfur metabolism to intracellular survival [21,25]. Indeed,
reduced sulfur compounds have been shown to play a critical role
in facilitating bacterial persistence in vivo [12]. Genes contributing
to the biosynthesis of these metabolites, such as cysH and sirA,
which direct the reduction of APS to sulfide [19,32], and cysM,
which is involved in cysteine biosynthesis [33,34], are also among
those induced by hydrogen peroxide and nutrient starvation.
Collectively, these genes are likely to facilitate bacterial adaptation
to the phagosomal environment.
Hypoxia is another environmental cue that has been correlated
with the upregulation of genes from the sulfate assimilation
pathway [23,24]. Transcription of cysD, cysNC, cysK2, and cysM is
induced by hypoxia, suggesting ATP sulfurylase and cysteine
biosynthesis may facilitate bacterial adaptation to oxygen-limiting
conditions. Because the granuloma has been shown to harbor
regions of low oxygen tension [4], it is plausible that sulfur
metabolism may be important in the transition to latency. The
finding that reduced sulfur compounds are critical to the onset of
chronic Mtb infection in mice lends additional support to this
hypothesis [12].
Certain antibiotics have also been shown to affect the
transcription of sulfur metabolism genes. Vancomycin, an
inhibitor of peptidoglycan biosynthesis, induces expression of
cysK2, cysD, and cysNC [29]. The cysNC gene is also induced by 5-
chloropyrazinamide, a pyrazinamide analog that irreversibly
inhibits fatty acid biosynthesis in vitro [20,35]. Furthermore,
cysA1, cysT, cysW, and subI are collectively induced by menadione,
a synthetic vitamin K precursor that promotes the formation of
reduced oxygen species [20,36]. These data suggest that sulfur
metabolism may modulate the bacterial response to certain drugs.
Evaluating Mtb susceptibility to these drugs upon overexpression of
related sulfur metabolism genes may reveal a more direct role for
the encoded enzymes in antibiotic resistance.
Indeed, several studies point to a role for sulfur-containing
compounds in bacterial detoxification pathways. In Salmonella
typhimurium, cysteine biosynthesis is required for the enhanced
antibiotic resistance of migrating swarm cells [37]. Similarly,
dysregulation of cysteine metabolism in Bacillus subtilis and
Staphylococcus aureus sensitizes the bacterial response to oxidative
stress and tellurite exposure [38,39]. Further, MSH exhibits well-
documented protective effects against free radicals, potent
oxidizing agents, alkylating agents, and certain antibiotics [14–
16,40,41], though is essential for ethionamide susceptibility and
was recently shown to be dispensable for Mtb growth [42]. Overall,
these findings underscore the importance of bacterial sulfur
metabolism to the detoxification of toxic species in the cell and
are consistent with the enhanced expression of Mtb sulfur
metabolism genes in response to oxidative stress and exposure to
certain antibiotics.
Transcriptional Regulators of Bacterial Sulfur Metabolism
In all likelihood, one or more transcriptional regulators mediate
the transcriptional response of the sulfate assimilation pathway to
extracellular signals. The alternative sigma factor SigH, which is
induced by phagocytosis and stress conditions, including acidic pH
and exposure to diamide, a thiol oxidizer, has been shown to
regulate the transcription of several sulfur metabolism genes (e.g.,
cysA1, cysT, cysW, cysD, and cysNC) following diamide treatment
[43]. SigH activity is regulated by the redox-sensitive anti-sigma
factor RshA [44]. Interestingly, the alternative sigma factor SigR
Table 1. Sulfur metabolism genes from M. tuberculosis induced by various conditions of environmental stress.
Stress Condition Genes Induced Reference
5-Chloropyrazinamide cysN [20]
Hydrogen peroxide cysD, cysNC
a, cysK2, cysM, cysT [21,22]
Hypoxia cysD, cysK2, cysN, cysM [23,24]
Macrophage infection cysD, cysN [21,25]
Menadione cysA1, cysT, cysW, subI [20]
Nutrient starvation cysA1, cysD, cysH, cysN, cysQ, cysT, cysW, sirA, subI [26,27]
SDS cysD, cysN [28]
Vancomycin cysD, cysK2, cysNC [29]
aThe cysN and cysC genes of Mtb are fused into a single, bifunctional cysNC gene [22]. However, the transcript is often reported as cysN in microarray data.
SDS, sodium dodecyl sulfate.
doi:10.1371/journal.ppat.1002036.t001
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by diamide and regulated by the redox-sensitive anti-sigma factor
RsrA (Figure 3) [45]. SigR and RsrA have been shown to
modulate MSH production in S. coelicolor in response to
intracellular MSH levels [45]. The strong dependence of MSH
biosynthesis on the sulfate assimilation pathway suggests that SigH
and RshA might similarly regulate the biosynthesis of this
ubiquitous thiol in mycobacteria.
In Escherichia coli, the majority of sulfate assimilation genes
belong to the cysteine (cys) regulon that is positively regulated by
the transcription factor CysB [46]. In the absence of inorganic
sulfate, a second transcription factor, Cbl, induces a series of
sulfate starvation-inducible (SSI) genes that coordinate the uptake
and subsequent metabolism of organosulfur compounds for the
generation of sulfite [47,48]. Comparable transcriptional regula-
tors have not yet been identified in mycobacteria.
Though the enzymes involved in sulfur metabolism are largely
conserved between these two prokaryotes, there are some notable
differences in the organization of their respective sulfate assimilation
pathways that caution against using the transcriptional regulatory
networks of E. coli as a blueprint for those of Mtb. For example, the
reductive branch of the Mtb sulfate assimilation pathway emanates
from APS, whereas E. coli initiates the biosynthesis of reduced sulfur
metabolites from PAPS [17]. Mtb also encodes four eukaryotic-like
sulfotransferases (stf0, stf1, stf2, and stf3), which are absent from E.
coli [11,49]. Further, Mtb encodes two independent pathways for
cysteine biosynthesis: the canonical pathway, which utilizes L-serine
(as in E. coli), and a novel route that utilizes O-phospho-L-serine
[33,50,51]. While these distinctions do not rule out the possibility of
a CysB-like master regulator in Mtb, they do suggest that the
transcriptional regulation of mycobacterial sulfur-metabolizing
enzymes may diverge considerably from that of E. coli. Additional
studies are needed to elucidate the transcriptional machinery
mediating the expression of these enzymes in Mtb. Notably, a
functional analog of CysB was recently identified in Corynebacterium
glutamicum, a gram-positive bacterium belonging to the same
suborder as Mtb, which will likely facilitate the search for related
proteins in mycobacteria [52].
Biochemical Regulation of Sulfur Metabolism
Sulfate Transporters
In addition to the various environmental conditions that
modulate sulfur metabolism at the transcriptional level, several
proteins regulate the metabolic pipeline by mediating the
availability of sulfate and its flux through the sulfate assimilation
pathway. Most notable are the sulfate transporters, which enable
the uptake of extracellular sulfate. The primary sulfate permease of
Mtb is an ABC transporter encoded by the subI-cysTWA1 operon
[53]. Genetic disruption of the cysA1 gene in M. bovis completely
inhibits sulfate uptake in vitro and renders the mutant auxotrophic
for methionine, yet does not impair bacterial survival in mice [53].
This implies either a strong reliance on methionine transport in
vivo, or the presence of other sulfate transporters that can
compensate for the loss of SubI-CysTWA1 activity during
infection. Notably, Mtb encodes two additional putative sulfate
transporters, Rv1739c and Rv1707, whose genes are induced 24 h
postinfection of activated macrophages [21,54]. Rv1739c expres-
sion in E. coli has been shown to enhance sulfate uptake, though
complementation of the M. bovis cysA1 mutant with the Rv1739c
gene is not sufficient to restore sulfate prototrophy [54]. In
contrast, little is known about the Rv1707 gene product. Assuming
all three of these transporters are functional, it is possible they
modulate sulfate uptake in response to discrete environmental
signals.
Figure 3. Feedback regulation of RsrA activity and SigR (s
R)-mediated transcription by MSH in S. coelicolor. The anti-sigma factor RsrA
binds the alternative sigma factor s
R in its reduced state (RsrA
red), preventing the association of s
R with RNA polymerase (RNA Pol). Under conditions
of oxidative stress (e.g., hydrogen peroxide or diamide treatment), RsrA is oxidized (RsrA
ox) and no longer binds s
R, enabling it to form a complex
with RNA polymerase, which induces the transcription of MSH biosynthetic genes. The reduction of oxidized RsrA by MSH facilitates sequestration of
s
R, which, in turn, suppresses MSH biosynthesis. Importantly, when oxidizing or alkylating agents deplete MSH levels, RsrA remains oxidized, which
stimulates s
R-mediated transcription and MSH biosynthesis [45,67].
doi:10.1371/journal.ppat.1002036.g003
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The sulfatases are a second class of proteins that likely
contribute to the intracellular concentration of free sulfate. These
enzymes catalyze the hydrolysis of sulfate esters from sulfated
proteins, peptides, and small molecules (Figure 4A) [55]. Type I
sulfatases are characterized by an active-site formylglycine residue
that is critical for catalysis [56]. The formylglycine is either co- or
post-translationally installed by a formylglycine-generating (FGE)
enzyme via oxidation of a conserved cysteine (Figure 4B). The Mtb
genome encodes six type I sulfatases, yet little is known about their
biochemistry [56]. One of these, AtsG, was recently shown to
possess arylsulfatase activity, but its native substrate has not been
identified [57]. In the absence of FGE, Mtb exhibits residual
sulfatase activity that may be attributed to FGE-independent type
II and type III sulfatases [56]. It is possible that some of these
enzymes are secreted and facilitate sulfate scavenging from the
host. Alternatively, they may hydrolyze sulfate from endogenous
metabolites to redirect the biosynthesis of sulfur-containing
compounds in response to evolving cellular needs. In either
scenario, these sulfatases are likely to regulate sulfur metabolism by
influencing sulfate availability.
The 39-Phosphoadenosine-59-Phosphatase CysQ
Another regulator of Mtb sulfur metabolism is CysQ, a 39-
phosphoadenosine-59-phosphatase. Unlike sulfate permeases and
sulfatases, whose activity directly influences the availability of free
sulfate, CysQ has the ability to modulate the levels of
intermediates that may affect flux through the sulfate assimilation
pathway. Specifically, CysQ dephosphorylates 39-phosphoadeno-
sine 59-phosphate (PAP), a byproduct of sulfotransferase reactions,
and its sulfated counterpart, PAPS [58]. Since PAP inhibits at least
one Mtb sulfotransferase [59], and PAPS accumulation is believed
to be cytotoxic [60], the degradation of these pathway interme-
diates by CysQ is likely to promote sulfation and balance sulfur
transactions in the cell. Interestingly, CysQ activity is inhibited by
alkali metal cations in vitro, including physiological concentrations
of sodium, and a homologous enzyme from Streptococcus mutans
confers resistance to superoxide stress [58,61]. These findings
suggest that CysQ may be sensitive to changes in the ionic
composition of the cytosol or to oxidative stress encountered
during the course of infection. If so, CysQ may modulate sulfur
metabolism in response to evolving environmental conditions.
Molecular Mechanisms of Sulfur Metabolism
Regulation
Small molecule regulation of sulfur metabolism is another
important mechanism directing the biosynthesis of sulfur-contain-
ing metabolites in bacteria. Though this phenomenon has not
been thoroughly investigated in Mtb, several paradigms have
emerged from other bacteria that may prove functional in
mycobacteria. While it is important to consider genus- and
species-specific variations in sulfur metabolism when drawing such
parallels [62], regulatory networks from other bacteria have often
guided the discovery of comparable pathways in Mtb [63–65] and
thus warrant further discussion.
In S. typhimurium, cysteine, sulfide, and thiosulfate have all been
shown to inhibit sulfate assimilation [46]. Cysteine does so by
inhibiting serine acetyltransferase, which catalyzes the formation
of O-acetylserine, the biosynthetic precursor of cysteine. In
contrast, sulfide and thiosulfate bind the CysB transcriptional
regulator, repressing the transcription of genes that facilitate
sulfide biosynthesis or in the case of thiosulfate, its uptake from
outside the cell. In E. coli, APS has been shown to inhibit Cbl-
mediated transcription, preventing the induction of SSI genes that
facilitate sulfur metabolism in the absence of inorganic sulfate [66].
Thus, APS may serve as a molecular barometer of sulfate
assimilation that modulates gene expression in response to sulfate
availability. While similar feedback mechanisms remain to be
elucidated in Mtb, they are likely to play an important role in
regulating sulfur metabolism. Consistent with this hypothesis,
transcription of the cysDNC operon of Mtb increases in response to
sulfur limitation and decreases following treatment with exogenous
cysteine [22].
Figure 4. Sulfatase biochemistry. (A) Sulfatase-catalyzed hydrolysis of a sulfated metabolite. (B) Modification of the active site cysteine of type I
sulfatases by FGE.
doi:10.1371/journal.ppat.1002036.g004
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metabolizing enzymes in Mtb. As mentioned previously, the
alternative sigma factor SigR from S. coelicolor has been shown to
modulate the biosynthesis of MSH in response to the intracellular
MSH concentration [45,67]. The current model of MSH
regulation revolves around the redox-sensitive anti-sigma factor
RsrA, which binds SigR in its reduced state, sequestering the
sigma factor and preventing it from binding RNA polymerase
(Figure 3). MSH facilitates this activity by maintaining RsrA in its
reduced state. Thus, when MSH is abundant, RsrA remains
active, suppressing MSH biosynthesis. However, when thiol-
reactive toxins overwhelm the cell’s MSH supply, RsrA is no
longer maintained in its reduced form, freeing SigR to induce
MSH biosynthesis. Given the importance of MSH in maintaining
the reducing environment of the cytosol and promoting resistance
to toxic oxidants [68], it is likely that a similar regulatory network
is in place to regulate its biosynthesis in mycobacteria.
Identifying Nodes of Regulatory Convergence in
Mtb Sulfur Metabolism
A global assessment of the transcriptional, biochemical, and
molecular mechanisms of sulfur metabolism regulation described
herein suggests nodes of regulatory convergence, or enzymes that
are sensitive to multiple regulatory cues. These enzymes are
apparently poised to tune flux through the sulfate assimilation
pathway in response to substrate availability and a broad range of
environmental signals. While many sulfur-metabolizing enzymes
are promising drug targets (please see the review by Bhave et al.
[6] for a comprehensive discussion), those that occupy key
positions in the regulatory landscape may be particularly strong
candidates for therapeutic intervention.
ATP sulfurylase and APS kinase, encoded by the cysDNC
operon, are the most prominent regulatory nodes to emerge from
this analysis. As illustrated in Figure 5, the cysD and cysNC genes
are consistently upregulated by diverse environmental cues,
including nutrient starvation [26,27], hypoxia [23,24], oxidative
stress [21,22], and cell wall stress [28,29]. These genes are also
induced upon phagocytosis [21,25], a process that integrates many
of these signals in vivo. Moreover, the catalytic activities of ATP
sulfurylase and APS kinase make them particularly susceptible to
biochemical regulatory cues. Together, these enzymes form the
sulfate-activating complex (SAC) of Mtb, which converts free
sulfate into PAPS [18]. Sulfate transporters, and possibly
sulfatases, indirectly regulate this complex by determining sulfate
availability in the cell. CysQ may also influence SAC activity by
affecting the equilibrium between PAPS and APS. Finally, both
cysteine and sulfate have been shown to modulate cysDNC
transcription [22], indicating these genes are subject to small
molecule regulation. In sum, ATP sulfurylase and APS kinase are
highly regulated enzymes whose inhibition may critically impair
Mtb sulfur metabolism.
Figure 5. Venn diagram illustrating the convergent transcriptional regulation of Mtb sulfur metabolism genes by various
conditions of environmental stress.
doi:10.1371/journal.ppat.1002036.g005
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GTPase (CysN) and sulfurylase (CysD) domains, possesses several
unique features that make it a particularly compelling drug target
[6]. Since this enzyme catalyzes the first committed step in the Mtb
sulfate assimilation pathway [18], its inhibition would eliminate
flux through the pathway. Further, significant structural, mecha-
nistic, and genetic features (e.g., the presence of a GTPase domain;
the fusion of cysN with cysC) distinguish ATP sulfurylase from its
human counterpart, which may facilitate the discovery of selective
inhibitors [6,18,69]. Consistent with these findings, CysD was
classified as a high-confidence drug target by an in silico target
identification program following an extensive series of systems-,
sequence-, and structure-based analyses [70].
Additional regulatory nodes suggested by the combined
transcriptional data (Figure 5) are cysK2, cysM, and the subI-
cysTWA1 operon. Both cysK2 and cysM are annotated as putative
O-acetyl-L-serine sulfhydrylases (OAS), enzymes that catalyze the
PLP-dependent biosynthesis of L-cysteine from O-acetyl-L-serine
and a sulfur donor such as sulfide [34]. In fact, a third gene, cysK1,
encodes the true OAS of Mtb [71]. CysM has been shown to
catalyze an alternate cysteine biosynthetic pathway that uses O-
phosphoserine as a substrate [33,51], while the role of CysK2 in
sulfur metabolism remains an enigma. Both cysK2 and cysM are
transcriptionally regulated by multiple environmental cues
(Table 1) [21,24,29,72]. Similarly, the subI-cysTWA1 operon,
which encodes the primary sulfate transport system of Mtb,i s
sensitive to diverse stress conditions [20,21,26,27]. CysT, CysW,
and CysK2 have also been classified as high-confidence drug
targets [70]. Thus, these enzymes warrant further biochemical
investigation and may prove attractive targets for the inhibition of
Mtb sulfur metabolism.
Conclusions and Perspectives
The sulfate assimilation pathway of Mtb is responsible for the
biosynthesis of sulfur-containing metabolites that influence bacte-
rial pathogenesis. The transcriptional regulation of this pathway in
response to multifarious environmental cues, including those
typically encountered in the phagosome, likely facilitates adapta-
tion to host immune cells. In addition, several proteins that
mediate the flux of sulfate through the pathway, such as sulfate
permeases, sulfatases, and the phosphatase CysQ, modulate the
biosynthesis of sulfur-containing compounds in response to the
evolving metabolic demands of the cell. Finally, the potential for
small molecule regulation of Mtb sulfur metabolism abounds; the
metabolites produced by the sulfate assimilation pathway are
themselves candidate regulators of this network, as evidenced by
cysteine and MSH in other bacteria. Realizing the extent of this
regulation remains an outstanding challenge in the field, as does
identifying the transcriptional proteins that orchestrate this
pathway’s response to the bacterial environment. Characterization
of CysK2 activity and the design of selective inhibitors targeting it
and other nodes of regulatory convergence, particularly ATP
sulfurylase, also warrant exploration. Addressing these aims will
not only advance our understanding of sulfur metabolism in Mtb,
but may also reveal a molecular linchpin whose inhibition could
dismantle an essential metabolic pathway in this ubiquitous
human pathogen.
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